CONMED (CNMD)

Search documents
Ahead of Conmed (CNMD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks Investment Research· 2024-01-30 15:21
Wall Street analysts expect Conmed (CNMD) to post quarterly earnings of $1.11 per share in its upcoming report, which indicates a year-over-year increase of 164.3%. Revenues are expected to be $332.94 million, up 32.7% from the year-ago quarter.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company announces its e ...
CONMED (CNMD) - 2023 Q3 - Earnings Call Transcript
2023-10-26 00:18
CONMED Corporation (NYSE:CNMD) Q3 2023 Earnings Conference Call October 25, 2023 4:30 PM ET Company Participants Curt Hartman – President and Chief Executive Officer Todd Garner – Executive Vice President and Chief Financial Officer Conference Call Participants Vik Chopra – Wells Fargo Robbie Marcus – J.P. Morgan Rick Wise – Stifel Matt O’Brien – Piper Sandler Kristen Stewart – CL King Carolyn Huszagh – Bank of America Operator Thank you for standing by. And welcome to CONMED’s Q3 Fiscal Year 2023 Earnings ...
CONMED (CNMD) - 2023 Q3 - Earnings Call Presentation
2023-10-25 21:09
Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer October 25, 2023 This presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forwardlooking statements herein or in previous disclosures. For example, in addition to general industr ...
CONMED (CNMD) - 2023 Q3 - Quarterly Report
2023-10-25 16:00
Selling and Administrative Expense Table of Contents Operating cash flows things, require the maintenance of certain financial ratios and restrict dividend payments and the incurrence of certain indebtedness and other activities, including acquisitions and dispositions. We were in full compliance with these covenants and restrictions as of September 30, 2023. We are also required, under certain circumstances, to make mandatory prepayments from net cash proceeds from any issuance of equity and asset sales. I ...
CONMED (CNMD) - 2023 Q2 - Earnings Call Transcript
2023-07-27 03:03
CONMED Corporation (NYSE:CNMD) Q2 2023 Earnings Conference Call July 26, 2023 4:30 PM ET Company Participants Curt Hartman - Chairman, President, and CEO Todd Garner - EVP and CFO Conference Call Participants Robert Marcus - JPMorgan Rick Wise - Stifel Matthew O'Brien - Piper Sandler Vik Chopra - Wells Fargo Matthew Mishan - KeyBanc Young Li - Jefferies Kristen Stewart - C.L. King Mike Matson - Needham & Company Operator Before the conference call begins, let me remind you that during this call, management ...
CONMED (CNMD) - 2023 Q2 - Earnings Call Presentation
2023-07-26 20:49
Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer July 26, 2023 in the power of engaged talent. ℃CONMED | Q2 2023 Earnings Call • Evolve product mix toward higher-growth, higher-margin offerings Q2 2023 Earnings Call | --- | --- | --- | --- | --- | --- | --- | |--------------------------------|---------------|-------------------------------|---------------------------------------------------------------------------- ...
CONMED (CNMD) - 2023 Q2 - Quarterly Report
2023-07-26 16:00
Washington, D.C. 20549 Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Indicate by check mark whether the registrant has submitted electronically every Interactive Data File re ...
CONMED (CNMD) - 2023 Q1 - Earnings Call Presentation
2023-04-27 03:06
WE DO WE MAKE and keep commitments. with urgency. Updated Full-Year 2023 Financial Guidance •Increased full-year adjusted cash EPS guidance to $3.30 - $3.50, from the prior range of $3.20 – $3.45, which continues to include between $0.20 and $0.25 of FX headwind Warehouse Software Implementation Update • Exited 2022 with approximately $30M of WMS related shippable backlog • Focus is on continuing to regain volumes that were affected by the disruption. The ultimate impact remains unknown, however, orders wer ...
CONMED (CNMD) - 2023 Q1 - Earnings Call Transcript
2023-04-27 03:06
CONMED Corporation (NYSE:CNMD) Q1 2023 Results Earnings Conference Call April 27, 2023 4:30 PM ET Company Participants Curt Hartman - Chair of the Board, President, and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Lilia-Celine Lozada - J.P. Morgan Ian Tolle - Bank of America Securities Vik Chopra - Wells Fargo Corporate & Investment Banking Matthew O'Brien - Piper Sandler Mike Matson - Needham & Company M ...
CONMED (CNMD) - 2023 Q1 - Quarterly Report
2023-04-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Common Stock, $0.01 par value CNMD NYSE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the ...